US appeals court upholds delay in Alzheimer's drug swap
A federal appeals court has rejected a drug manufacturer's appeal and affirmed a judge's order that Actavis PLC keep distributing its widely used Alzheimer's medication until after its patent expires this summer.
May 22, 2015